Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ahmed H. Al‐jedai"'
Autor:
Nahla A. Azzam, Abdulelah Almutairdi, Hajer Y. Almudaiheem, Turki AlAmeel, Shakir A. Bakkari, Othman R. Alharbi, Khalidah A. Alenzi, Maha A. AlMolaiki, Bedor A. Al-Omari, Rayan G. Albarakati, Ahmed H. Al-Jedai, Omar I. Saadah, Majid A. Almadi, Badr Al-Bawardy, Mahmoud H. Mosli
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 30, Iss 4, Pp 181-197 (2024)
The management of inflammatory bowel disease (IBD) in pregnant women is challenging and must be addressed on a patient-by-patient basis. Optimal patient management requires a multidisciplinary team and clear evidence-based recommendations that cater
Externí odkaz:
https://doaj.org/article/221581c5c41942efb5c38220966c2c21
Autor:
Maysa T. Eshmawi, Hajer Yousef Al-Mudaiheem, Mohammed Fatani, Yousef Binamer, Mohammed Alajlan, Ru’aa Alharithy, Hend Alotaibi, Hind M. Almohanna, Adel Alsantali, Abdulaziz Madani, Nadya Al-Faraidy, Falk G. Bechara, Ahmed H. Al-Jedai
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Purpose: There is limited information about the diagnosis and treatment of hidradenitis suppurativa (HS) in the Kingdom of Saudi Arabia (KSA). This Delphi consensus study was conducted to develop recommendations for the management of HS in the KSA.Me
Externí odkaz:
https://doaj.org/article/23debf434ce442bdb277f3795ecc0de8
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 2, Pp 101952- (2024)
Purpose: Our study aims to provide an overview of medication therapy monitoring practices carried out by pharmacists in hospitals across the Gulf Cooperation Council (GCC) countries. Methods: This is a cross-sectional questionnaire-based study of hos
Externí odkaz:
https://doaj.org/article/795ad7be7d3e4bbc9a7f7682be012acc
Autor:
Ahmed Y. Mayet, Fowad Khurshid, Hussain A. Al-Omar, Sarah S Alghanem, Mohammed S. Alsultan, Ahmed H. Al-jedai
Publikováno v:
Saudi Pharmaceutical Journal, Vol 31, Iss 3, Pp 453-461 (2023)
Purpose: To outline dispensing and administration practices in hospital pharmacy across the Gulf Cooperation Councils (GCC) countries’ hospitals. Paucity of data in appraising hospital pharmacy practice in GCC regions motivated us to conduct this s
Externí odkaz:
https://doaj.org/article/594be95a71d0440eac4eb199913d9260
Autor:
Zohair Al Aseri FRCPC EM, CCM, Farjah H. AlGahtani MD, MPH, Majid F. Bakheet MD, Ahmed H. Al-Jedai PharmD, Sarah Almubrik MD
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics, Vol 28 (2023)
The indications of direct oral anticoagulants (DOACs) have expanded over the past 15 years. DOACs are effective and safe oral anticoagulants associated with lower bleeding risks and mortality than vitamin K antagonists. However, DOAC users are prone
Externí odkaz:
https://doaj.org/article/fbb0c0c8a85444d89c996f15f02f41a8
Autor:
Ahmed H. Al-jedai, Fowad Khurshid, Ahmed Y. Mayet, Hussain A. Al-Omar, Sarah S. Alghanem, Mohammed S. Alsultan
Publikováno v:
Saudi Pharmaceutical Journal, Vol 29, Iss 9, Pp 1021-1028 (2021)
Purpose: To outline hospital pharmacy practices across the Gulf Cooperation Councils (GCC) countries’ hospitals. Methods: A modified survey questionnaire was prepared from the original 2019 American Society of Health-System Pharmacist (ASHP) survey
Externí odkaz:
https://doaj.org/article/72f9c9397b61455699016cb3cc2c6952
Autor:
Mona M. Al-Khawajah, Rayan G. Al-Barakati, Ahmed H. Al-Jedai, Yaser M. Al-Malik, Hajer Y. Al-Mudaiheem, Bedor A. Al-Omari, Ibtisam A. Al-Thubaiti, Rumaiza H. Al-Yafeai, Reem F. Bunyan, Edward J. Cupler, Mohammed Hakami, Hanaa M. Kedah, Seraj Makkawi, Leena H. Saeed, Jameelah A. Saeedi, Eslam Shosha, Mohammed A. Al-Jumah
Publikováno v:
Clinical and Translational Neuroscience, Vol 7, Iss 2, p 10 (2023)
This review article addresses the complex issues faced by individuals with Multiple Sclerosis (MS) who are planning a family, becoming pregnant, or wishing to breastfeed their baby. Recommendations and guidelines were discussed and agreed upon by neu
Externí odkaz:
https://doaj.org/article/ccafe79615864522b8ba712a494b9cfd
Autor:
Ibtisam A. Al Thubaiti, Mona M. AlKhawajah, Norah Al Fugham, Dema A. Alissa, Ahmed H. Al-Jedai, Yaser M. Al Malik, Mousa A. Almejally, Hajer Y. Al-Mudaiheem, Bedor A. Al-Omari, Hessa S. AlOtaibi, Rumaiza H. Al Yafeai, Mohammed A. Babakkor, Reem F. Bunyan, Edward J. Cupler, Mohammed Hakami, Hanaa M. Kedah, Seraj Makkawi, Leena H. Saeed, Jameelah A. Saeedi, Eslam Shosha, Mohammed A. Al Jumah
Publikováno v:
Clinical and Translational Neuroscience, Vol 7, Iss 1, p 6 (2023)
This article deals with recommendations on the management of symptoms of MS and on the provision of vaccinations in patients receiving disease-modifying therapies (DMTs). Symptoms of MS, such as fatigue, depression, urinary symptoms, spasticity, impa
Externí odkaz:
https://doaj.org/article/2183e4d78c6e4b98b414b3349982ffa1
Autor:
Jameelah A. Saeedi, Rumaiza H. AlYafeai, Abdulaziz M. AlAbdulSalam, Abdulaziz Y. Al-Dihan, Azeeza A. AlDwaihi, Awad A. Al Harbi, Yaser I. Aljadhai, Ahmed H. Al-Jedai, Nuha M. AlKhawajah, Majed M. Al-Luqmani, Abdulrahman O. AlMalki, Hajer Y. Al-Mudaiheem, Hind A. AlNajashi, Rayan A. AlShareef, Amani A. AlShehri, Faisal Y. AlThekair, Nabila S. Ben Slimane, Edward J. Cupler, Mamdouh H. Kalakatawi, Hanaa M. Kedah, Yaser M. Al Malik, Ibtisam A. Althubaiti, Reem F. Bunyan, Eslam Shosha, Mohammed A. Al Jumah
Publikováno v:
Clinical and Translational Neuroscience, Vol 7, Iss 1, p 5 (2023)
Multiple sclerosis (MS) is an inflammatory neurological illness common in young adults. The prevalence and incidence of MS are regionally and globally increasing. Recent data from Saudi Arabia (SA) estimate the prevalence to be 40.40 cases per 100,00
Externí odkaz:
https://doaj.org/article/385a27ecd356445782f7362af1ca2957
Autor:
Yaser M. Al Malik, Ibtisam A. Al Thubaiti, Maha A. AlAmmari, Norah Al Fugham, Eman N. Ali, Dema A. Alissa, Salman A. Aljarallah, Ahmed H. Al-Jedai, Maeed A. AlKathiri, Mona M. AlKhawajah, Mousa A. Almejally, Hajer Y. Al-Mudaiheem, Hessa S. Al Otaibi, Ghadah H. AlTowaijri, Rumaiza H. Al Yafeai, Mohammed A. Babakkor, Saeed A. Bohlega, Reem F. Bunyan, Edward J. Cupler, Mohammed Hakami, Abid M. Kareem, Amr M. Khardaly, Seraj Makkawi, Leena H. Saeed, Jameelah A. Saeedi, Eslam Shosha, Mohammad A. Al Jumah
Publikováno v:
Clinical and Translational Neuroscience, Vol 6, Iss 4, p 27 (2022)
For the past 10 years, disease-modifying therapy (DMT) options for multiple sclerosis (MS) have grown remarkably where DMTs have been shown to reduce the risk of MS relapses. MS patients are advised to begin treatment with a DMT shortly after diagnos
Externí odkaz:
https://doaj.org/article/2fb7ce205ae64e98a94d6195cedec570